• Home
  • CHRNA5
  • Mouse Anti-CHRNA5 Recombinant Antibody (CBYY-C3166)

Mouse Anti-CHRNA5 Recombinant Antibody (CBYY-C3166) (CBMAB-C4609-YY)

See all CHRNA5 antibodies
Go to compare Compare Online Inquiry
Published Data
CBMAB-C4609-YY-1
Mouse Anti-CHRNA5 Recombinant Antibody (CBYY-C3166) (CBMAB-C4609-YY) in IF
Co-localization of CHRNA subunits in HBO cells.
Dual immunostaining was used to co-localize CHRNA subunits in individual HBO cells. (A and B) Show immunostaining of CHRNA5 (α5) with CHRNA4 (α4). The panels show confocal images of α5 (green), α4 (red), DAPI (blue), and merged images of DAPI and dual fluorescence labels. (C and D) Show immunostaining of CHRNA5 (α5) with CHRNA3 (α3). The panels show confocal images of α5 (green), α3 (red), DAPI (blue), and merged images of DAPI and dual fluorescence labels. ...View More
Qian, J., Mummalaneni, S., Larsen, J., Grider, J. R., Spielman, A. I., Özdener, M. H., & Lyall, V. (2018). Nicotinic acetylcholine receptor (CHRN) expression and function in cultured human adult fungiform (HBO) taste cells. PLoS One, 13(3), e0194089.
Distributed under Open Access license CC BY 4.0, without modification.
CBMAB-C4609-YY-2
Mouse Anti-CHRNA5 Recombinant Antibody (CBYY-C3166) (CBMAB-C4609-YY) in IF
Co-localization of CHRNA5 subunit with TRPM5 in HBO cells.
Dual immunostaining was used to co-localize CHRNA5 (α5) subunit with TRPM5 in individual HBO cells. (A and B) Show confocal images of α5 (green), TRPM5 (red), DAPI (blue), and merged images of DAPI and dual fluorescence labels. ...View More
Qian, J., Mummalaneni, S., Larsen, J., Grider, J. R., Spielman, A. I., Özdener, M. H., & Lyall, V. (2018). Nicotinic acetylcholine receptor (CHRN) expression and function in cultured human adult fungiform (HBO) taste cells. PLoS One, 13(3), e0194089.
Distributed under Open Access license CC BY 4.0, without modification.
Datasheet
SDS
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal
Mouse
Clone
CBYY-C3166
Application
ELISA, WB, FC
Immunogen
Purified recombinant fragment of human Nicotinic Acetylcholine R alpha 5/CHRNA5 (AA 23-254).
Host Species
Mouse
Specificity
Human, Rat
Antibody Isotype
IgG2a
Clonality
Monoclonal Antibody
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.
ApplicationNote
WB1:100-1:1,000
IP1-2 µg per 100-500 µg of total protein (1 ml of cell lysate)
IF(ICC)1:50-1:500
ELISA1:100-1:1,000
IHC-P1:50-1:500
WB1:100-1:2,000
ELISA1:100-1:2,000
FC1:10-1:1,000

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS
Preservative
0.05% sodium azide
Concentration
1 mg/ml
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
More Infomation

Target

Full Name
Cholinergic Receptor Nicotinic Alpha 5 Subunit
Entrez Gene ID
Human1138
Mouse110835
Pig100156023
UniProt ID
HumanP30532
MouseQ2MKA5
PigA0A287AQW1
Alternative Names
AHUS5, ARMD9, ASPa, C3b, CPAMD1, HEL-S-62p, C3
Function
After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Biological Process
Behavioral response to nicotine Source: UniProtKB
Chemical synaptic transmission Source: GO_Central
Ion transmembrane transport Source: GO_Central
Nervous system process Source: GO_Central
Regulation of membrane potential Source: GO_Central
Regulation of synaptic vesicle exocytosis Source: Ensembl
Response to nicotine Source: GO_Central
Signal transduction Source: GO_Central
Synaptic transmission, cholinergic Source: GO_Central
Cellular Location
Postsynaptic cell membrane; Cell membrane
Topology
Extracellular: 23-254
Helical: 255-275
Helical: 282-302
Helical: 317-337
Cytoplasmic: 338-429
Helical: 430-451
Extracellular: 452-468

Forget, B., Icick, R., Robert, J., Correia, C., Prevost, M. S., Gielen, M., ... & Maskos, U. (2021). Alterations in nicotinic receptor alpha5 subunit gene differentially impact early and later stages of cocaine addiction: a translational study in transgenic rats and patients. Progress in Neurobiology, 197, 101898.

Brynildsen, J. K., & Blendy, J. A. (2021). Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms. Neuropharmacology, 186, 108480.

Chen, L. S., Baker, T. B., Miller, J. P., Bray, M., Smock, N., Chen, J., ... & Bierut, L. J. (2020). Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a randomized placebo‐controlled trial. Clinical Pharmacology & Therapeutics, 108(6), 1315-1325.

Venkatesan, S., & Lambe, E. K. (2020). Chrna5 is essential for a rapid and protected response to optogenetic release of endogenous acetylcholine in prefrontal cortex. Journal of Neuroscience, 40(38), 7255-7268.

Tam, A., Obeidat, M., Hackett, T. L., Dorscheid, D. R., Singhera, G., Hogg, J. C., & Sin, D. D. (2019). Cholinergic Receptor Nicotinic Alpha 5 Expression in the Airways of Patients with Chronic Obstructive Pulmonary Disease. In B64. COPD: MECHANISM AND TREATMENT (pp. A3845-A3845). American Thoracic Society.

Lin, C. H., Lee, H. H., Kuei, C. H., Lin, H. Y., Lu, L. S., Lee, F. P., ... & Lin, Y. F. (2019). Nicotinic acetylcholine receptor subunit Alpha-5 promotes radioresistance via recruiting E2F activity in oral squamous cell carcinoma. Journal of clinical medicine, 8(9), 1454.

Tomaz, P. R. X., Santos, J. R., Scholz, J., Abe, T. O., Gaya, P. V., Negrão, A. B., ... & Santos, P. C. J. L. (2018). Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women. BMC medical genetics, 19(1), 1-8.

Cingir Koker, S., Jahja, E., Shehwana, H., Keskus, A. G., & Konu, O. (2018). Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer. PloS one, 13(12), e0208982.

Köker, Ş. C. (2018). Effects of Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi on apoptosis, DNA damage response, drug sensitivity, and HSA-MIR-495-3P overexpression in breast cancer (Doctoral dissertation, Bilkent University).

Morton, G., Nasirova, N., Sparks, D. W., Brodsky, M., Sivakumaran, S., Lambe, E. K., & Turner, E. E. (2018). Chrna5-expressing neurons in the interpeduncular nucleus mediate aversion primed by prior stimulation or nicotine exposure. Journal of Neuroscience, 38(31), 6900-6920.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-CHRNA5 Recombinant Antibody (CBYY-C3166)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Rat Anti-CHRNA5 Recombinant Antibody (C6194) (CAT#: CBMAB-C6194-LY)

Mouse Anti-CHRNA5 Recombinant Antibody (CBT2919) (CAT#: V2LY-0625-LY754)

Mouse Anti-CHRNA5 Recombinant Antibody (BA0287) (CAT#: CBMAB-0243CQ)

Mouse Anti-CHRNA5 Recombinant Antibody (7D3) (CAT#: CBMAB-C8625-LY)

Mouse Anti-CHRNA5 Recombinant Antibody (CBT4210) (CAT#: V2LY-0625-LY755)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry
Request bulk or custom quote Second antibody and isotype control

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry